To determine the agents of recurrence, the demographic features, and the management and outcomes of pterygium cases treated at Aga Khan University Hospital (AKUH), Karachi. This hospital-based descriptive study included 147 patients with pterygium (147 eyes) from both sexes, who presented at the Ophthalmology Department at AKUH between January 1, 2002 and December 31, 2010. Data regarding their demographic profile and other factors were collected in a well-structured proforma. Data were analyzed using frequencies, proportions, group means, standard deviations, and Pearson’s chi squared test. The male to female ratio in our study was 2:1, with factors such as younger age (<50 years) at presentation (P = 0.04, Pearson’s chi squared test) and the presence of secondary pterygium (P = 0.050) correlated significantly with the recurrence of pterygium. There was a definite trend of decreased recurrence seen with lower grade of pterygium (P = 0.06). The recurrence rate in our study was 8.8 %. These results suggest that a younger age coupled with a higher grade of pterygium as well as a history of multiple recurrences leads to increased susceptibility of recurrence after surgical excision. Early diagnosis and appropriate management will lead to a better prognosis.
Pterygium Recurrence Pterygium grade Etiologic factors Age
This is a preview of subscription content, log in to check access.
The authors are greatly indebted to Dr. Tashfeen Ahmad, Associate Professor, Department of Surgery, AKUH for his assistance in statistical analysis.
Conflict of interest
No conflicting relationship exists for any author.
Ang LP, Chua JL, Tan DT (2007) Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol 18(4):308–313PubMedCrossRefGoogle Scholar
Gupta VP, Saxena T (2003) Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery. Indian J Ophthalmol 51:59–65PubMedGoogle Scholar
Mahar PS, Manzar N, Ahmad K (2011) The effect of intra-operative use of topical mitomycin-C on intra-ocular pressure in patients with pterygium excision. Asian J Ophthalmol 12:144–148Google Scholar
Mutlu FM, Sobaci G, Tatar T, Yildirim E (1999) A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology 106:817–821PubMedCrossRefGoogle Scholar
Sharma A, Gupta A, Ram J, Gupta A (2000) Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers 31:301–307PubMedGoogle Scholar
Kunitomo N, Mori S (1963) Studies on the pterygium. Part 4. A treatment of the pterygium by mitomycin C instillation. Acta Soc Ophthalmol Jpn 67:601–607Google Scholar
Hayasaka S, Noda S, Yamamoto Y et al (1988) Postoperative instillation of low dose mitomycin-C in the treatment of primary pterygium. Am J Ophthalmol 106:715–718PubMedCrossRefGoogle Scholar
Rachmiel R, Leibe H, Levartovsky S (1995) Results of treatment with topical mitomycin C 0.02 % following excision of primary pterygium. Br J Ophthalmol 79:233–239PubMedCrossRefGoogle Scholar
Panda A, Das GK, Tuli SW, Kumar A (1998) Randomized trial of intra-operative mitomycin C in surgery for pterygium. Am J Ophthalmol 125:59–63PubMedCrossRefGoogle Scholar
Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105(5):901–904PubMedCrossRefGoogle Scholar
Rahman A, Yahya K, Shariful Hasan K (2008) Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C. J Coll Physicians Surg Pak 18(8):489–492PubMedGoogle Scholar
Cheng HC, Tseng SH, Kao PL, Chen FK (2001) Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea 20(1):24–29PubMedCrossRefGoogle Scholar
Narsani AK, Jatoi SM, Gul S, Dabir SA (2008) Treatment of primary pterygium with conjunctival autograft and mitomycin C. A comparative study. J Liaquat Uni Med Health Sci 7(3):184–187Google Scholar
Frucht-pery J, Raiskup F, Ilsar M, Landau D, Orucov F, Solomon A (2006) Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence. Am J Ophthalmol 141(6):1044–1050PubMedCrossRefGoogle Scholar
Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ (1995) A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 120(2):151–160PubMedGoogle Scholar
Mastropasqua L, Carpineto P, Ciancaglini M et al (1996) Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 80:288–291PubMedCrossRefGoogle Scholar
Mahar PS (1996) Role of mitomycin-C in reducing the recurrence of pterygium after surgery. Pak J Ophthalmol 12(3):91–94Google Scholar
Díaz L, Villegas VM, Emanuelli A, Izquierdo NJ (2008) Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery. Cornea 27(10):1119–1121PubMedCrossRefGoogle Scholar
Tan DTH, Chee SP, Dear KBG et al (1997) Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115:1235–1240PubMedCrossRefGoogle Scholar